CStone Pharmaceuticals (STU:PH4) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is CStone Pharmaceuticals ROE % Adjusted to Book Value?

CStone Pharmaceuticals's ROE % for the quarter that ended in Jun. 2023 was -88.64%. CStone Pharmaceuticals's PB Ratio for the quarter that ended in Jun. 2023 was N/A. CStone Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was N/A.

CStone Pharmaceuticals ROE % Adjusted to Book Value Historical Data

The historical data trend for CStone Pharmaceuticals's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CStone Pharmaceuticals ROE % Adjusted to Book Value Chart

CStone Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-43.68

-13.53

-16.04

-10.27

-14.15

CStone Pharmaceuticals Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial									-22.01	-12.74	-14.43	-	-

Competitive Comparison of CStone Pharmaceuticals's ROE % Adjusted to Book Value

For the Biotechnology subindustry, CStone Pharmaceuticals's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CStone Pharmaceuticals's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CStone Pharmaceuticals's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where CStone Pharmaceuticals's ROE % Adjusted to Book Value falls into.

CStone Pharmaceuticals ROE % Adjusted to Book Value Calculation

CStone Pharmaceuticals's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-78.93%	/	5.58
	=	-14.15%

CStone Pharmaceuticals's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-88.64%	/	N/A
	=	N/A

CStone Pharmaceuticals ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of CStone Pharmaceuticals's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

CStone Pharmaceuticals (STU:PH4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CStone Pharmaceuticals (STU:PH4) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

CSPHF:USA 02616:Hong Kong

Address

218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Shanghai, CHN, 215123

Website

https://www.cstonepharma.com

CStone Pharmaceuticals is engaged in the development and commercialization of innovative tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.

CStone Pharmaceuticals (STU:PH4) Headlines

No Headlines